Revance Therapeutics
IPO · NASDAQ: RVNC
Clinical stage biotech through public market debut.
Portfolio
This is not a list of checks written. It is the set of companies whose problems we have already run at, and the reason we can tell a founder what usually happens next.
Our role varies by company. In some we put in capital, in others we supply embedded operating support or go to market leadership, and in many it is a combination of all three.
Featured outcomes
IPO · NASDAQ: RVNC
Clinical stage biotech through public market debut.
IPO · NYSE: SI
Bank infrastructure for digital asset markets.
Acquired · Concur
Consumer travel search with a design-led wedge.
Acquired · Google
Mobile productivity suite absorbed into Workspace.
Retail scale · 2.4x revenue
Bluetooth trackers from hardware hit to durable business.
Category leader · DTC
Farm-direct flowers with a subscription engine.
Full index
9 companies
8 companies
7 companies
12 companies
8 companies
Our field reports show the workstreams, the numbers, and the structure of a single engagement, start to finish.
Read a field report